AESC 2022 CME Items

Thank you for attending the 64th Annual meeting of the AESC!  Continuing medical education is an important part of our conference, and to comply with the rules, there are a few items for which we ask your assistance . . .

Conference Evaluation

An important aspect of the CME process is for the audience to evaluate the conference as a whole, as well as each speaker.  This year we once again will be using online evaluations which allows you to do the speaker evaluations in "real time" (or at least at the end of each session.  Click on the links below to access evaluation forms for each day's speakers, as well as an overall evaluation that you should complete at the end of the conference.  We strongly encourage all members to complete the evaluation as it is extremely useful for future planning, as well as representing a critical aspect of our accreditation.

CLICK ON THE LINKS BELOW TO ACCESS THE EVALUATION FORMS

• WEDNESDAY speakers
• THURSDAY speakers
• FRIDAY speakers
• SATURDAY speakers
   
• OVERALL conference evaluation (submit at the end of the meeting)

Claim Form

IMPORTANT -- Your meeting packet includes a form with which to claim your CME credits.  Please make sure to fill it out and return to Rich or Kathy Paul at the Club registration area before you leave the meeting.  The form lists the total number of credits available...but of course, each participant should claim only the credits you actually earned by attending the scientific sessions.

If you lose your CME claim form, please check at the meeting registration area for a copy.  We are unable to issue CME credits without a claim form.  We ask that you turn in the form before you leave the meeting.  But in any event, we cannot accept a claim after August 9 which is when we will be issuing credit certificates and closing out the process.

Thank you for your assistance in complying with these important functions.  

CME Accreditation Statement

This activity is planned and implemented by the Indiana Academy of Ophthalmology (IAO) and the American Eye Study Club. IAO is accredited by the Indiana State Medical Association to provide continuing education for physicians.

The Indiana Academy of Ophthalmology designates this live activity for a maximum of 13.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

After completing this activity, the participant should be better able to:
1. Discuss advances and new techniques in ophthalmic surgery and medical treatment of eye diseases, including glaucoma, cataract, cornea, retina, neuro-ophthalmology, pediatrics and oculoplastics.
2. Describe factors relating to basic science, current research, and new discoveries relating to a variety of eye diseases and conditions.
3. Explain how new medical treatment options can help to improve management of eye diseases in a variety of subspecialties.
4. List methods that can be employed in an ophthalmology practice to improve patient safety and enhance the efficiency of patient/practice management.
5. Discuss ways in which knowledge can be applied across various ophthalmic subspecialties.
7. Discuss how public policies and third party payor procedures impact upon the quality of care available and an ophthalmologist’s ability to provide effective care to patients.
8. Describe how practicing ophthalmologists can be effective advocates for their patients, particularly with respect to public policy development.

Faculty and Conflict of Interest Disclosures

 
The following individuals are giving lectures or are participating in panel discussions:

Chris Albanis MD; Arbor Centers for Eye Center; Chicago IL
Keith Hugh Baratz MD; Mayo Clinic; Rochester MN
Robert M. Beardsley MD; Oregon Eye Consultants; Eugene OR
Nicholas P. Bell MD; Eye Center of Texas; Bellaire TX
Jesse L. Berry MD; Children's Hospital; Los Angeles Altadena CA
Lynn K. Byerly MD; Naples Eye Physicians; Naples FL
Cynthia S. Chiu MD; East Bay Eye Specialist;s Pacifica CA
William S. Clifford MD; Fry Eye Associates; Garden City KS
Joseph M. Coney MD; Retina Associates of Cleveland, Inc;. Beachwood OH
Matthew A. Cunningham MD; Florida Retina Institute; Orlando FL
Derek W. Del Monte MD; Carolina Eye Associates; Summerfield NC
Jinali Rajesh Diora MD; Northern Virginia Ophthalmology Associates; Vienna VA
Forrest James Ellis MD; Northern Virginia Ophthalmology Associates, PC; Falls Church VA
K. David Epley MD ;Children's Eye Care, PLLC; Kirkland WA
Christopher B. Estopinal MD; Virginia Eye Institute;Richmond VA
Bradley D. Fouraker MD; Brandon Eye Clinic; Tampa FL
Benjamin Frankfort MD; PhD Baylor College of Medicine-Cullen Eye Institute; Houston TX
Sanjay "Sonny" Goel MD; Goel Vision; Clarksville MD
Robert S. Gold MD Eye Physicians of Central Florida; Maitland FL
;Curtis L. Hagedorn MD; Colorado Retina Associates; Denver CO
Sohail Hasan MD PhD; Illinois Retina Associates SC; Orland Park IL
Jeffrey D. Henderer MD; Temple University School of Medicine - Dept. of Ophthalmology; Haverford PA
P. Lloyd Hildebrand MD; FACS PCEO New Eyes Las Vegas; Las Vegas NV
Glen G. Hoar MD; North Island Eye Center; Comox, BC Canada
Erich Horn MD MBA; University of Florida - Dept. of Ophthalmology; Gainesville FL
Krishna S. Kishor MD; Bascom Palmer Eye Institute; Palm Beach Gardens FL
Shree K. Kurup MD; Retina Centers; Tucson AZ
Janice C. Law MD; Vanderbilt Eye Institute; Nashville TN
Steven D. McLeod MD; American Academy of Ophthalmology; San Francisco CA
Jeff S. Maltzman MD; Fishkind, Bakewell & Maltzman Eye Care & Surgery Center; Tucson AZ
Robert F. Melendez MD MBA; Juliette Eye Institute; Albuquerque NM
Aaron Miller MD MBA; Houston Eye Associates; Spring TX
Darby D. Miller MD MPH; Mayo Clinic, Jacksonville; Jacksonville FL
Faruk H. Orge MD; Rainbow Babies Childrens Hospital Case Western Reserve University; Cleveland OH
Purnima Sharad Patel MD; Emory Eye Center; Atlanta GA
David Plager MD; Indiana University; Indianapolis IN
Aleksandra V. Rachitskaya MD; Cleveland Clinic Cole Eye Institute; Cleveland OH
Leela V. Raju MD; NYU Langone Eye Center; New York NY
Adam C. Reynolds MD; Intermountain Eye & Laser Center; Eagle ID
Arvind Saini MD MBA; Hidden Valley Eye Associates; Escondido CA
James C. Tsai MD; New York Eye & Ear Infirmary; New York NY
David E. Vollman MD MBA; Washington University School of Medicine;St. Louis MO
Aaron P. Weingeist MD; Clearview Eye & Laser, PLLC; Seattle WA
Robert E. Wiggins , Jr. MD, MHA; Asheville Eye Associates; Asheville NC
Michelle S. Ying MD MSPH; Carolina Cataract & Laser Center; Ladson SC

These program participants have disclosed the following potential conflicts of interest:

• Jesse Berry MD -- Consultant:  Immunocore, Castle Biosciences, Biotissue; Shareholder:  Doximity, Figs; Grants/Principal Investigator:  National Cancer Institute, The Wright Foundation, Children's Oncology Group/St. Baldrick's Foundation, The nights Templar Eye Foundation, Hyundai Hope on Wheels, Childhood Eye Cancer Trust, Children's Cancer Research Fund, The Berle & Lucy Adams Chair in Cancer Research, The Larry and Celia Moh Foundation, The Institute for Families, Inc. Children's Hospital Los Angeles; Provisional Patent:  Aqueous humor cell free DNA for diagnostic and Prognostic evaluation of ophthalmic disease; Prognostic characterization of DNA methylation signatures for retinoblastoma using the aqueous humor liquid biopsy.
• Joseph Coney MD -- Consultant: Alimera Sciences, Appellis, Regenxbio; Speakers Bureau:  Alimera Sciences, Allergan/Abbvie, Appellis, Genentech, Novartis, Regeneron, Regenxbio; Grant Research Support:  Alimera Sciences, Allergan/AbbVie, Appellis, Genentech, MacTel, National Eye Institute, Novartis, Regeneron, Regenxbio; Honoraris:  Allergan/AbbVie, Novartis
• Forrest James Ellis, MD -- Stock Shareholder and Employee/Owner:  JelliSee Ophthalmics Inc.
• K. David Epley, MD -- Consultant:  Vyluma; Shareholder:  Abbott, AbbVie, Novartis
• Benjamin Frankfort, MD PhD -- Grant Research Support:  National Institutes of Health, Research to Prevent Blindness, Clayton Foundation for Research
• P. Lloyd Hildebrand, MD -- Shareholder:  Trinoveon Corporation; Employee/Owner:  Trinoveon Corporation (Founder)
• David Plager, MD -- Grant Research Support and Shareholder:  Ocular Therapeutix; 
• Leela Raju, MD -- Shareholder:  RPS
• Arvind Saini, MD MBA -- Shareholder:  Rxst
• James Tsai, MD -- Consultant:  Eyenovia, ReNetX Bio, Smartlens